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Abstract
Background: Recent studies have shown an increase in the incidence of oral squamous cell carcinoma (OSCC) in 
younger patients. The hypothesis that tumors could be hormonally induced during pregnancy or in young female 
patients without the well-known risk factors alcohol or tobacco abuse seems to be plausible. 
Material and Methods: Estrogen Receptor alpha (ERα) and Progesterone Receptor (PR) expression were analyzed 
in normal oral mucosa (n=5), oral precursor lesions (simple hyperplasia, n=11; squamous intraepithelial neoplasia, 
SIN I-III, n=35), and OSCC specimen. OSCCs were stratified in a young female (n=7) study cohort and older 
patients (n=46). In the young female study cohort three patients (n=3/7) developed OSCC during or shortly after 
pregnancy. Breast cancer tissues were used as positive control for ERα and PR expression.
Results: ERα expression was found in four oral precursor lesions (squamous intraepithelial neoplasia, SIN I-III, 
n=4/35, 11%) and in five OSCC specimen (n=5/46, 11%). The five ERα positive OSCC samples were older male 
patients. All patients within the young female study cohort were negatively stained for both ERα and PR. 
Conclusions: ER expression could be regarded as a seldom risk factor for OSCC. PR expression seems to be not 
relevant for the development of OSCC.
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Introduction 
Oral squamous cell carcinoma (OSCC) is typically re-
garded to be a disease that predominantly affects older 
males (1,2). Intriguingly, recent studies have shown an 
increase in the incidence of OSCC in young female pa-
tients without the well-known causes of OSCC like al-
cohol and tobacco abuse (2-4). The etiology and patho-
genesis of oral cavity cancer in young female patients 
could be different from those occurring in older patients 
(3,5). Pregnancy has been shown to be associated with 
OSCC but there is a paucity of data regarding this etiol-
ogy as these studies are primarily case reports discuss-
ing the challenges that clinicians face in administering 
treatment that is of maximal benefit to the patient and 
minimal risk to the fetus (4,6-10).
The hypothesis that tumors could be hormonally in-
duced during pregnancy or in young female patients 
without the well-known risk factors seems to be plau-
sible. However, it has not yet been determined whether 
or not a biological predisposition to OSCC exists. In the 
context of oral cavity carcinogenesis, studies have been 
shown that hormone receptors, like Estrogen Receptor 
(ER) and Progesterone Receptor (PR) expression could 
be regarded as a biological predisposition factor for 
OSCC (11-15).
Therefore, in our study we compare a series of OSCCs, 
which were stratified in a young (<45 years (16)) female 
study cohort and older OSCC patients. In the young 
female OSCC study cohort three patients developed 
OSCC during or shortly after pregnancy. 
Analysis of the mechanistic basis in OSCC develop-
ment in the context of a multistep carcinogenetic proc-
ess through morphologically and clinically detectable 
precancerous stages (17) may harbour the availability of 
molecular tools to selectively and experimentally ma-
nipulate this multistep process. Therefore, ER and PR 
expression has been additionally analyzed in squamous 
intraepithelial neoplasia (SIN) lesions.
Material and Methods
- Patients and Tumor Specimen 
The records of healthy individuals (normal oral mucosal 
tissues, n=5), patients with oral precursor lesions (sim-
ple hyperplasia, n=11; squamous intraepithelial neopla-
sia SIN I, n=5; SIN II, n=9; SIN III, severe dysplasia, 
n=10; SIN III, carcinoma in situ, n=11), and patients 
with invasive OSCC were retrospectively assessed from 
January 2009 to November 2014. OSCCs were strati-
fied in a young (<45 years (16)) female (n=7, Table 1) 
study cohort and older patients (n=46, Table 2) (18). In 
the young female study cohort three patients (n=3/7) 
developed OSCC during or shortly after pregnancy. 
The diagnosis of normal oral mucosal tissues, precur-
sor lesions, and invasive squamous cell carcinoma 
was confirmed by the department of Pathology, Uni-
versity Hospital Tuebingen. The material was archival 
formalin-fixed, paraffin-embedded tissue from routine 
histopathological work-ups. Both OSCC study cohorts 
were negatively assessed for human papillomavirus 
(HPV) in routine analysis by using fluorescence in-situ 
hybridization (FISH) testing. The material has been 
stored with permission of the local ethics committee of 
the University Hospital Tuebingen (approval number: 
562-2013BO2), after informed consent obtained from 
the patients prior to surgical resection. Tumor blocks 
of paraffin-embedded tissue were selected by experi-
enced pathologists, based on routine H&E stained sec-
tions. Sections from all available tissues underwent 
histopathological assessment, blinded to the prior his-
topathology report. Serial tissue sections (2 µm thick-
ness) were cut from formalin-fixed paraffin-embedded 
(FFPE) blocks on a microtome and mounted from warm 
Characteristics Number of Patients
Total n=7
Age (years)
(range 30-42, mean 36)
Histological Grading
                         G1 1
G2 4
G3 2
G4 0
Depth of invasion
 pT1 1
 pT2 3
 pT3 2
 pT4 1
Cervical lymph node metastasis
pN0 3
pN1 2
pN2 2
pN3 0
UICC stage
UICC I 1
UICC II 1
UICC III 1
UICC IV 4
Distant metastasis
yes 0
no 7
Site distribution of OSCC
Tongue 3 
Floor of the mouth 3
Palate 0 
Buccal mucosa 0 Alveolar ridge 1 
Table 1. Clinicopathological characteristics of 7 young fe-
male patients with OSCC.
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water onto adhesive microscope slides. First, we as-
sessed H&E stained sections from each tissue section to 
differentiate between normal tissue, precursor lesions, 
tumor cell areas, stromal areas, and infiltrating immune 
cells. Breast cancer tissues were used as a representa-
tive positive control. Oral precursor lesions were clas-
sified according to WHO criteria (17). Tumor staging 
was performed according to the 7th edition of the TNM 
staging system by the UICC/ AJCC of 2010. Grading of 
OSCC was defined according to WHO criteria. 
- Staining procedure and quantification of immunohis-
tochemistry
We stained for Estrogen Receptor alpha (ERα, Dako 
Cytomation, Hamburg, Germany, rabbit mAb, Code 
M3643, Clone EP1, dilution 1:50), Progesterone Recep-
tor (PR, Dako Cytomation, mouse mAb, Code M3569, 
Clone PgR 636, dilution 1:50), and mouse/rabbit isotype 
controls (BD Pharmingen, Heidelberg, Germany) in 
tissue sections. Staining was performed on serial sec-
tions of 2µm thickness, which were deparaffinized in 
xylene and ethanol and rehydrated in water. Heat in-
duced epitope retrieval (HIER) was performed with ei-
ther citrate buffer pH 6.0 (Dako, Hamburg, Germany) 
or EDTA buffer pH 9.0. Endogenous peroxidase activ-
ity was quenched with 0.3% hydrogen peroxide. En-
dogenous biotin activity was blocked using the avidin/
biotin blocking kit (Vector Laboratories, Burlingame, 
CA, USA). After incubation with the primary or rab-
bit control antibody (BD Pharmingen, Heidelberg, Ger-
many (19) the Dako LSAB2 peroxidase System (Dako, 
Hamburg) was used. Slides were subsequently incu-
bated for 3-5 minutes in DAB (3,3’-diaminobenzidine, 
Biogenex) counterstained with haemalaun and mounted 
with Glycergel (Dako). 
Five representative high power fields (1 HPF = 0.237 
mm2, original magnification: x200-fold) were analyzed. 
The extent of the staining, defined as the percentage of 
positive staining areas of tumor cells in relation to the 
whole tissue area, was semi-quantitatively scored. A 
positive result was defined as nuclear staining in ≥1% 
of tumor cells (20). Two observers blinded to the diag-
nosis performed scoring on identical sections marked 
by circling with a water-resistant pencil and finally with 
diamond-tipped pencil on the opposite side of the micro-
scopic slide. Pictures were analyzed using a Canon cam-
era (Krefeld, Germany). The photographed images were 
imported into the Microsoft Office Picture Manager. 
- Statistical analysis
Statistical analysis was performed with MedCalc Soft-
ware, Version 15.8 (Mariakerke, Belgium). Descriptive 
statistics were generated according to case-control sta-
tus.
Results
- Expression of ERα and PR in normal mucosa, oral 
precursor lesions and OSCC
Breast cancer tissues were used as a representative posi-
tive control for studying ERα and PR expression (Fig. 
1). ERα expression was not found in normal oral mu-
cosa (n=0/5) and simple hyperplasia (n=0/11) but in four 
oral precursor lesions (squamous intraepithelial neopla-
sia, SIN I-III, n=4/35, 11%) and in five OSCC specimen 
(n=5/46, 11%, Fig. 2). Positive ERα expression was only 
found in the older-aged OSCC study cohort. The five 
positive samples were older male (age: 54-73 years) pa-
tients (no female). All patients within the young female 
study cohort (n=7, including the three OSCC patients, 
who developed the tumor during or shortly after preg-
nancy) were negatively stained for ERα.
PR expression was not found in normal oral mucosa 
(n=0/5), oral precursor lesions (simple hyperplasia, 
n=0/11; squamous intraepithelial neoplasia, SIN I-III, 
n=0/35), and OSCC specimen of both study cohorts 
(older-aged OSCC patients, n=0/46; young female 
OSCC patients n=0/7).
Characteristics Number of Patients
Total n=46
Age (years)
(range 47-87, mean 65)
Gender
Male 26
Female 20
Histological Grading
G1 6
G2 29
G3 10
G4 1
Depth of invasion
pT1 12
pT2 11
pT3 7
pT4 16
Cervical lymph node metastasis
pN0 29
pN1 4
pN2 11
pN3 2
UICC stage
UICC I 9
UICC II 7
UICC III 6
UICC IV 24
Distant metastasis
yes 2
no 44
Site distribution of OSCC
Tongue 12 
Floor of the mouth 20
Palate 6 
Buccal mucosa 1 Alveolar ridge 7 
Table 2. Clinicopathological characteristics of 46 patients with 
OSCC.
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Discussion
In-vitro studies have shown ERα expression in OSCC 
cell lines and tumors. The treatment with tamoxifen 
significantly inhibits OSCC cell proliferation and inva-
sion (14,15,21-23). Therefore, the usage of tamoxifen for 
targeted therapies may be useful for hormonally active 
OSCCs. In our study, we analyzed the ERα subunit as 
the alpha subunit plays a predominant role in the pro-
motion of cell growth and survival (24). A study of 24 
OSCC specimens demonstrated that the frequency of 
ERα expression was 50% (15). Moreover, a previous 
study by Chang et al. (14) showed that ERα immuno-
reactivity was observed in 43% of malignant lesions, 
whereas none of benign lesions showed ERα immu-
noreactivity. In our survey, by using well established 
monoclonal antibodies we detected 11% positive OSCC 
samples, which is much lower than the reported preva-
lence in the current literature but 11% positive SIN le-
sions that hasn t´ been reported as yet. 
The activation status of ERα and the regulatory mecha-
nism of ERα activation in OSCC cells are mostly un-
known (14). The results published by Chang et al. (14) 
suggest that ERα activity can be enhanced by focal 
adhesion kinase (FAK)/Protein kinase B (AKT) sig-
nalling, which is critical for promoting cell growth in 
Fig. 1. HE staining and immunohistochemical stain-
ing of ERα and PR in breast cancer. HE staining (A) 
shows tumor cells (asterisks) and normal mammary 
gland tissue (arrows). Immunohistochemical stain-
ing shows representative images of positive ERα (B) 
and PR (C) expression in breast cancer as a positive 
control (asterisks). Brown chromogen color (3,3’-Di-
aminobenzidine) indicates positive nuclear staining, 
the blue color shows the nuclear counterstaining by 
hematoxylin (original magnification: x100-fold). HE, 
Haematoxylin and eosin; ERα, Estrogen Receptor al-
pha; PR, Progesterone Receptor. 
Fig. 2. Immunohistochemical staining of ERα in 
OSCC. Immunohistochemical staining shows repre-
sentative images of positive ERα expression (A, B) in 
OSCC (asterisks). Brown chromogen color (3,3’-Di-
aminobenzidine) indicates positive nuclear staining, 
the blue color shows the nuclear counterstaining by 
hematoxylin. The square box demonstrates the area 
of interest (original magnification: x100-fold, upper 
panel, A), which is also shown in larger magnification 
(x400-fold, lower panel, B). ERα, Estrogen Receptor 
alpha; OSCC, oral squamous cell carcinoma.
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OSCC cell lines. Moreover, a cross-talk between ER 
and epidermal growth factor receptor (EGFR) in head 
and neck squamous cell carcinoma cell lines has been 
reported (25). 
Intriguingly, positive ERα expression was only found 
in the older-aged OSCC study cohort. The five positive 
samples were older male patients (no female). All pa-
tients within the young female study cohort (including 
the three OSCC patients, who developed the tumor dur-
ing or shortly after pregnancy) were negatively stained 
for both ERα and PR. Therefore, sexual hormone recep-
tor expression could not be regarded as a risk factor for 
young female OSCC patients or pregnancy. The reason 
for ERα expression in older male patients remains un-
clear.
Conclusions 
Based on the results of the present study sexual hormone 
receptor expression is not associated with young OSCC 
female patients or pregnancy. ER expression could be 
regarded as a seldom risk factor for OSCC, whereas PR 
expression seems to be not relevant for the development 
of OSCC.
- Abbreviations
SIN, squamous intraepithelial neoplasia; OSCC, oral 
squamous cell carcinoma; ERα, Estrogen Receptor al-
pha; PR, Progesterone Receptor.
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